These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35444797)

  • 1. Nothing to Cheer About: Endorsing  Imaginary Economic Evaluations and Value Claims with CHEERS 22.
    Langley P
    F1000Res; 2022; 11():248. PubMed ID: 35444797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facilitating bias in cost-effectiveness analysis: CHEERS 2022 and the creation of assumption-driven imaginary value claims in health technology assessment.
    Langley P
    F1000Res; 2022; 11():993. PubMed ID: 36226039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force.
    Husereau D; Drummond M; Petrou S; Carswell C; Moher D; Greenberg D; Augustovski F; Briggs AH; Mauskopf J; Loder E;
    Value Health; 2013; 16(2):231-50. PubMed ID: 23538175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More Unnecessary Imaginary Worlds - Part 1: The Institute for Clinical and Economic Review's Evidence Report on Janus Kinase (JAK) Inhibitors in Rheumatoid Arthritis.
    Langley PC
    Innov Pharm; 2020; 11(1):. PubMed ID: 34017631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsense on Stilts - Part 1: The ICER 2020-2023 Value Assessment Framework for Constructing Imaginary Worlds.
    Langley PC
    Innov Pharm; 2020; 11(1):. PubMed ID: 34017624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicaid Formulary Decisions and the Institute for Clinical and Economic Review: Abandoning Pseudoscience in Imaginary Pharmaceutical Pricing Claims.
    Langley PC
    Innov Pharm; 2021; 12(1):. PubMed ID: 34007677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ICER, ISPOR AND QALYs: Tales of Imaginary Worlds.
    Langley PC
    Innov Pharm; 2019; 10(4):. PubMed ID: 34007578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force.
    Husereau D; Drummond M; Augustovski F; de Bekker-Grob E; Briggs AH; Carswell C; Caulley L; Chaiyakunapruk N; Greenberg D; Loder E; Mauskopf J; Mullins CD; Petrou S; Pwu RF; Staniszewska S
    Value Health; 2022 Jan; 25(1):10-31. PubMed ID: 35031088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consolidated Health Economic Evaluation Reporting Standards - Value of Information (CHEERS-VOI): Explanation and Elaboration.
    Kunst N; Siu A; Drummond M; Grimm SE; Grutters J; Husereau D; Koffijberg H; Rothery C; Wilson ECF; Heath A
    Value Health; 2023 Oct; 26(10):1461-1473. PubMed ID: 37414276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supping with the Devil: Belief and the Imaginary World of Multiple Myeloma Therapies Invented by the Institute for Clinical and Economic Review.
    Langley PC
    Innov Pharm; 2021; 12(3):. PubMed ID: 35601587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review of reporting quality of economic evaluations in plastic surgery based on the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.
    Miroshnychenko A; Uhlman K; Malone J; Waltho D; Thoma A
    J Plast Reconstr Aesthet Surg; 2021 Oct; 74(10):2458-2466. PubMed ID: 34217645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impossible QALY and the Denial of Fundamental Measurement: Rejecting the University of Washington Value Assessment of Targeted Immune Modulators (TIMS) in Ulcerative Colitis for the Institute for Clinical and Economic Review (ICER).
    Langley PC
    Innov Pharm; 2020; 11(3):. PubMed ID: 34007634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations.
    Husereau D; Drummond M; Augustovski F; de Bekker-Grob E; Briggs AH; Carswell C; Caulley L; Chaiyakunapruk N; Greenberg D; Loder E; Mauskopf J; Mullins CD; Petrou S; Pwu RF; Staniszewska S;
    J Med Econ; 2022 Jan; 25(sup1):1-7. PubMed ID: 35012427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.
    Husereau D; Drummond M; Petrou S; Carswell C; Moher D; Greenberg D; Augustovski F; Briggs AH; Mauskopf J; Loder E;
    J Med Econ; 2013; 16(6):713-9. PubMed ID: 23521434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.
    Husereau D; Drummond M; Petrou S; Carswell C; Moher D; Greenberg D; Augustovski F; Briggs AH; Mauskopf J; Loder E;
    Int J Technol Assess Health Care; 2013 Apr; 29(2):117-22. PubMed ID: 23587340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.
    Husereau D; Drummond M; Petrou S; Carswell C; Moher D; Greenberg D; Augustovski F; Briggs AH; Mauskopf J; Loder E;
    BMJ; 2013 Mar; 346():f1049. PubMed ID: 23529982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The National Pharmaceutical Council: Endorsing the Construction of Imaginary Worlds in Health Technology Assessment.
    Langley PC
    Pharmacy (Basel); 2020 Jul; 8(3):. PubMed ID: 32668706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations.
    Husereau D; Drummond M; Augustovski F; de Bekker-Grob E; Briggs AH; Carswell C; Caulley L; Chaiyakunapruk N; Greenberg D; Loder E; Mauskopf J; Mullins CD; Petrou S; Pwu RF; Staniszewska S;
    Int J Technol Assess Health Care; 2022 Jan; 38(1):e13. PubMed ID: 35007499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations.
    Husereau D; Drummond M; Augustovski F; de Bekker-Grob E; Briggs AH; Carswell C; Caulley L; Chaiyakunapruk N; Greenberg D; Loder E; Mauskopf J; Mullins CD; Petrou S; Pwu RF; Staniszewska S;
    Eur J Health Econ; 2022 Nov; 23(8):1309-1317. PubMed ID: 35084632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.
    Husereau D; Drummond M; Petrou S; Carswell C; Moher D; Greenberg D; Augustovski F; Briggs AH; Mauskopf J; Loder E
    Pharmacoeconomics; 2013 May; 31(5):361-7. PubMed ID: 23529207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.